ETOPOSIDE - Study

DRUG2 trials

Sponsors

Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB Chair, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions

MedulloblastomaSmall Cell Lung Cancer

Phase 2

Pharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms

Active, not recruitingNCT01064466

Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB ChairSmall Cell Lung Cancer

Start: 2025-07-16End: 2026-12-28Target: 600Updated: 2026-08-27

Arsenic Trioxide Combined With Chemotherapy for Relapsed SHH-Activated and/or TP53-Mutant Medulloblastoma

Not yet recruitingNCT07856069

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityMedulloblastoma

Start: 2026-10-01End: 2034-10-01Target: 78Updated: 2026-10-02